Globus Medical’s Blockbuster Finish Sets a High-Stakes 2026 Showdown
AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) delivered a powerful year-end surge, posting preliminary fourth-quarter sales of about $823.2 million and capping 2025 with roughly $2.936 billion in revenue, …
Globus Medical’s Blockbuster Finish Sets a High-Stakes 2026 Showdown Read More